The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $93.87

Today's change+3.36 +3.71%
Updated February 10 12:47 PM EST. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $93.87

Today's change+3.36 +3.71%
Updated February 10 12:47 PM EST. Delayed by at least 15 minutes.

CVS Health Corp up sharply

CVS Health Corp is up sharply today, rallying (U.S.)$3.36 or 3.71% to (U.S.)$93.87. Over the last five days, shares have lost 1.57% and are down 3.99% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $91.20
  • Previous close(U.S.) $90.51
  • High(U.S.) $93.92
  • Low(U.S.) $91.06
  • Bid / Ask(U.S.) $93.86 / (U.S.) $93.88
  • YTD % change-3.99%
  • Volume4,292,556
  • Average volume (10-day)6,023,076
  • Average volume (1-month)5,470,677
  • Average volume (3-month)5,667,030
  • 52-week range(U.S.) $81.37 to (U.S.) $113.65
  • Beta0.87
  • Trailing P/E21.10×
  • P/E 1 year forward15.52×
  • Forward PEG1.11×
  • Indicated annual dividend(U.S.) $1.70
  • Dividend yield1.81%
  • Trailing EPS(U.S.) $4.45
Updated February 10 12:47 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.39%

Based on its net profit margin of 3.39%, CVS Health Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.19%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue38,64437,16936,33237,055
Total other revenue--------
Total revenue38,64437,16936,33237,055
Gross profit6,6616,4026,1646,633
Total cost of revenue31,98330,76730,16830,422
Total operating expense36,31334,90734,20034,734
Selling / general / administrative4,3304,1404,0324,312
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0----0
Other operating expenses, total--------
Operating income2,3312,2622,1322,321
Interest income (expense), net non-operating-268-171-137-135
Gain (loss) on sale of assets--------
Other--------
Income before tax2,0702,0961,9982,190
Income after tax1,2371,2721,2211,322
Income tax, total833824777868
Net income1,2461,2721,2211,321
Total adjustments to net income--------
Net income before extra. items1,2361,2721,2211,322
Minority interest-1----0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2361,2721,2211,322
Inc. avail. to common incl. extra. items1,2461,2721,2211,321
Diluted net income1,2461,2721,2211,321
Dilution adjustment--------
Diluted weighted average shares1,1211,1321,1361,151
Diluted EPS excluding extraordinary itemsvalue per share1.101.121.071.15
Dividends per sharevalue per share0.350.350.350.28
Diluted normalized EPSvalue per share1.101.121.071.15